FDA Recruits Patients, Advocates For Development Forum
In another step to make its work more patient-friendly, US FDA is recruiting members for a patient advocacy group that will focus on medical product development.
You may also be interested in...
Patients and patient advocacy groups at the US FDA's inaugural Patient Engagement Advisory Committee meeting said they need sponsors to minimize the burdens and augment the comforts of trial participation, and get reports on outcomes along the way. Meanwhile, industry groups worried about revealing too much confidential business information, and biasing trial outcomes.
The US FDA released updated safety information on Endologix Inc.’s AFX2 Endovascular abdominal aortic aneurysm (AAA) graft system on Tuesday. Previous devices in the product line have been associated with an increased risk of abnormal bleeding.
Radiofrequencies from the incontinence-sensing devices may interfere with other medical equipment in a hospital setting.